VU Research Portal
Cardiovascular Disease in Inflammatory Joint Disorders
Agca, Rabia
2021
document version
Publisher's PDF, also known as Version of record
Link to publication in VU Research Portal
citation for published version (APA)
Agca, R. (2021). Cardiovascular Disease in Inflammatory Joint Disorders: The interplay between risk factors,
inflammation and therapy. GVO drukkers.
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal ? Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
E-mail address:
vuresearchportal.ub@vu.nl
Contents
Chapter 1 General introduction
Section 1 Cardiovascular risk factors in rheumatoid arthritis and psoriatic arthritis
Chapter 2 Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders Chapter 3 Co-existent subclinical hypothyroidism is associated with an increased risk of cardiovascular
events in patients with rheumatoid arthritis
Chapter 4 IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis
Chapter 5 The effects of 5 year etanercept therapy on cardiovascular risk factors in patients with psoriatic arthritis
Section 2 Magnitude of cardiovascular risk in rheumatoid arthritis and other inflammatory joint disorders
Chapter 6 Cardiovascular Event Risk in Rheumatoid Arthritis is Higher than in Type 2 Diabetes: a 15 Year Longitudinal study
Chapter 7 EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update
Section 3 Novel Factors associated with Cardiovascular Risk in Rheumatoid Arthritis
Chapter 8 Noncanonical NF-κB signaling in microvessels of atherosclerotic lesions is associated with inflammatory cell infiltration, atheromatous plaque morphology and myocardial infarction Chapter 9 Arterial wall inflammation on 18F-FDG-PET/CT is increased in patients with rheumatoid
arthritis as compared with osteoarthritis, as a marker of early atherosclerosis
Chapter 10 Arterial wall inflammation in rheumatoid arthritis is reduced by anti-inflammatory treatment Chapter 11 Interferon regulatory factor 5 (IRF5) gene variants rs2004640 and rs4728142 are associated
with carotid intima media thickness but not with cardiovascular events in rheumatoid arthritis
Chapter 12 General Discussion and Summary
Nederlandse samenvatting
Appendices Dankwoord Curriculum vitae Publicaties
